Thought Leadership

 

Key Role for Patient Advocacy Groups in Rare Disease Drug Development: Making Better Use of This Valuable Resource

Monday, August 24 | 8:50 - 9:10 AM

Ray Huml, Vice President of Medical and Scientific Strategy and Head of Syneos Health’s Rare Disease Consortium

When 
Mon, Aug 24, 10:30 am to Thu, Aug 27, 10:30 am
Additional Details